"Deprescriptions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Directions written to discontinue use of PRESCRIPTION DRUGS in order to reduce unnecessary and/or excessive medications (see POLYPHARMACY), DRUG SIDE EFFECTS and ADVERSE DRUG REACTION.
| Descriptor ID |
D000069340
|
| MeSH Number(s) |
E02.319.698.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Deprescriptions".
Below are MeSH descriptors whose meaning is more specific than "Deprescriptions".
This graph shows the total number of publications written about "Deprescriptions" by people in this website by year, and whether "Deprescriptions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 6 | 1 | 7 |
| 2018 | 4 | 2 | 6 |
| 2019 | 2 | 1 | 3 |
| 2020 | 3 | 10 | 13 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Deprescriptions" by people in Profiles.
-
Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target. Monaldi Arch Chest Dis. 2021 May 04; 91(2).
-
Clinical course of COVID-19 disease in immunosuppressed renal transplant patients Turk J Med Sci. 2021 04 30; 51(2):428-434.
-
How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician. World J Gastroenterol. 2021 Mar 21; 27(11):1022-1042.
-
COVID-19 in IBD: The experience of a single tertiary IBD center. Dig Liver Dis. 2021 03; 53(3):271-276.
-
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3. Arthritis Rheumatol. 2021 02; 73(2):e1-e12.
-
Deprescribing in older adults during COVID-19 pandemic; Opportunity or risk? Res Social Adm Pharm. 2021 05; 17(5):1024-1025.
-
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient. Transpl Infect Dis. 2021 Apr; 23(2):e13501.
-
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021 Feb; 22(2):229-240.
-
Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. Eur J Heart Fail. 2020 12; 22(12):2205-2215.
-
Managing rheumatic diseases during COVID-19. Clin Rheumatol. 2020 Nov; 39(11):3245-3254.